Harmony Biosciences Holdings (NASDAQ:HRMY): A Value Stock with Strong Financial Health
Harmony Biosciences (HRMY) passes a Decent Value screen with strong valuation, profitability, and health scores, offering quality at a reasonable price in the pharmaceuticals industry.
Read the full article5d agoen
You might also wanna read
A Look at Biogen Inc (BIIB) After 5.0% Gain -- GF Value $191.79 vs Price $209.03
Related Stocks: BIIB
GuruFocus·3d ago
Cancer therapy spinout Myricx Bio agrees to US$1.5B acquisition by Novartis
Myricx Bio, a cancer therapy spinout based on research carried out at the Francis Crick Institute and Imperial College London, has reached a
crick.ac.uk·10d ago
NewBioRX: The Life Sciences Supplier Helping Raise Expectations In The Wellness Industry
In the world of life sciences, excellence is often defined by the ability to deliver reliable results time and time again, making quality re
Maxim·2d ago
Biogen Is Paying $1 Billion for a Company That Won't Say What It Makes. Here's Why That's Actually Good News for BIIB Investors.
This could be a key move for future growth.
Bars·12d ago
FMR LLC's Strategic Acquisition of Climb Bio Inc Shares
Related Stocks: CLYM , AAPL , AMZN , GOOGL , MSFT , NVDA
GuruFocus·1d ago
VYNE Therapeutics declares special cash dividend with Yarrow Bioscience merger
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
thefly.com·6d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.